Market Access

For this Interview with the Innova­tors series, several interviews were conducted with executives and scien­tists from Genmab, an international biotech company with 23 years of experience in de­veloping cutting-edge antibodies and anti­body technology. The participants discussed a diverse range of topics, including the com­pany’s ability to develop products at scale to serve the entire range of stakeholders in the healthcare ecosystem, the importance of Genmab’s data- and science-driven approach to research, and the innovative corporate cul­ture at the heart of the company’s evolution.